{"editorial":{"content_id":"9dd4d166-c5a3-454c-a807-443f091d9c3b","slug":"pamella-dias-assifarma-intercron-20261023-e14e28","content_type":"news","title":"Pamella Dias 兼任 Assifarma 与 Intercron 执行董事","summary":"Pamella Dias 出任 Assifarma 新任执行董事，同时继续领导自2024年起任职的 Intercron。","body":"Pamella Dias 出任 Assifarma 新任执行董事，并将同时继续领导她自2024年起执掌的 Intercron。\n\n据来源介绍，她的优先事项包括加强协会主义、扩大商业机会，以及拉近与关联网络所涉行业和合作伙伴的关系。\n\nPamella 拥有超过15年零售业经验，职业生涯建立在自有品牌、商业战略和业务发展方面，曾任职于 Walmart 和 DIA Brasil。她拥有企业管理学位，并在 FGV 获得人员管理和领导力方向的研究生学历和 MBA。\n\n来源还公布了她的两个联系邮箱：pamella.dias@assifarma.com.br 和 pamella.dias@intercron.com.br。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["人事变动","企业动态","行业趋势","br-health"],"content_level":"编辑整理","event_type":"公司动态","audience_tags":[],"event_location":null,"verification_status":"unverified","published_at":"2026-10-23T23:03:00.942Z","display_date":"2026-10-23","source_published_at":null,"source_url":"https://panoramafarmaceutico.com.br/executiva-acumula-direcao-da-assifarma-e-da-intercron/","source_name":"Panorama Farmacêutico","source_language":"pt","author_name":"编辑部","risk_level":"medium","risk_flags":[],"opportunity_flags":[],"trend_signals":[]},"intelligence":null,"meta":{"canonical_url":"https://chinabrazilinsight.com/news/pamella-dias-assifarma-intercron-20261023-e14e28","api_url":"https://chinabrazilinsight.com/api/public/content/pamella-dias-assifarma-intercron-20261023-e14e28","markdown_url":"https://chinabrazilinsight.com/api/public/content/pamella-dias-assifarma-intercron-20261023-e14e28?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/pamella-dias-assifarma-intercron-20261023-e14e28?view=json","last_updated":"2026-10-23T23:03:27.679Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}